Anxiolytic-like effects of substance P administration into the dorsal, but not ventral, hippocampus and its influence on serotonin

[1]  H. Dringenberg,et al.  Electrical stimulation of dorsal, but not ventral hippocampus reduces behavioral defense in the elevated plus maze and shock-probe burying test in rats , 2008, Behavioural Brain Research.

[2]  R. Clark,et al.  Recognition memory and the medial temporal lobe: a new perspective , 2007, Nature Reviews Neuroscience.

[3]  M. Brandão,et al.  Substance P injected into the dorsal periaqueductal gray causes anxiogenic effects similar to the long-term isolation as assessed by ultrasound vocalizations measurements , 2007, Behavioural Brain Research.

[4]  D. Treit,et al.  The role of hippocampus in anxiety: intracerebral infusion studies , 2007, Behavioural pharmacology.

[5]  D. Treit,et al.  The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus , 2007, Behavioural pharmacology.

[6]  T. Nabeshima,et al.  Brain serotonin depletion impairs short-term memory, but not long-term memory in rats , 2007, Physiology & Behavior.

[7]  F. Guimarães,et al.  Anxiolytic effects induced by inhibition of the nitric oxide–cGMP pathway in the rat dorsal hippocampus , 2007, Psychopharmacology.

[8]  E. Dere,et al.  Reinstatement of episodic-like memory in rats by neurokinin-1 receptor antagonism , 2007, Neurobiology of Learning and Memory.

[9]  S. J. Martin,et al.  The rodent hippocampus and spatial memory: from synapses to systems , 2007, Cellular and Molecular Life Sciences.

[10]  E. Asprodini,et al.  Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus , 2006, Neuroscience.

[11]  C. Lever,et al.  Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats , 2006, The European journal of neuroscience.

[12]  Costas Papatheodoropoulos,et al.  Differential expression of γ‐aminobutyric acid‐A receptor subunits in rat dorsal and ventral hippocampus , 2005, Journal of neuroscience research.

[13]  M. Brandão,et al.  Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[14]  A. Rex,et al.  Anxiety but not arousal increases 5‐hydroxytryptamine release in the rat ventral hippocampus in vivo , 2005, The European journal of neuroscience.

[15]  L. Schiapparelli,et al.  Serotonin 5‐HT1A receptor blockade enhances Ca2+/calmodulin‐dependent protein kinase II function and membrane expression of AMPA receptor subunits in the rat hippocampus: implications for memory formation , 2005, Journal of neurochemistry.

[16]  S. McLean.  Do substance P and the NK1 receptor have a role in depression and anxiety? , 2005, Current pharmaceutical design.

[17]  F. Holsboer,et al.  Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression‐like behaviour: effects of chronic paroxetine treatment , 2005, Journal of neurochemistry.

[18]  S. D. de Boer,et al.  Long-term effects of social stress on brain and behavior: a focus on hippocampal functioning , 2005, Neuroscience & Biobehavioral Reviews.

[19]  M. Brandão,et al.  Neurokinin-1 receptor antagonism by SR140333: enhanced in vivo ACh in the hippocampus and promnestic post-trial effects , 2004, Peptides.

[20]  F. S. Duarte,et al.  Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats , 2004, Behavioural Brain Research.

[21]  H. Eichenbaum.  Hippocampus Cognitive Processes and Neural Representations that Underlie Declarative Memory , 2004, Neuron.

[22]  J. Rawlins,et al.  Regional dissociations within the hippocampus—memory and anxiety , 2004, Neuroscience & Biobehavioral Reviews.

[23]  L. Jarrard,et al.  The hippocampus and inhibitory learning: a ‘Gray’ area? , 2004, Neuroscience & Biobehavioral Reviews.

[24]  C. Maggi,et al.  Tachykinins and tachykinin receptors: a growing family. , 2004, Life sciences.

[25]  Neil McNaughton,et al.  Hebb, Pandemonium and Catastrophic Hypermnesia: The Hippocampus as a Suppressor of Inappropriate Associations , 2003, Cortex.

[26]  F. Bloom,et al.  Neuropeptides: opportunities for drug discovery , 2003, The Lancet Neurology.

[27]  M. Raggenbass,et al.  Action of tachykinins in the rat hippocampus: modulation of inhibitory synaptic transmission , 2003, The European journal of neuroscience.

[28]  S. Boyce,et al.  The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils , 2003, Neuropharmacology.

[29]  C. Belzung,et al.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. , 2003, European journal of pharmacology.

[30]  J. Glowinski,et al.  Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites , 2003, Neuroscience.

[31]  D. Treit,et al.  Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests , 2002, Brain Research.

[32]  M. Moser,et al.  Reduced fear expression after lesions of the ventral hippocampus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Brandão,et al.  Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray. , 2001, European journal of pharmacology.

[34]  R. S. Sloviter,et al.  Substance P receptor expression by inhibitory interneurons of the rat hippocampus: Enhanced detection using improved immunocytochemical methods for the preservation and colocalization of GABA and other neuronal markers , 2001, The Journal of comparative neurology.

[35]  D. Treit,et al.  The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal l-glutamate , 2001, Brain Research.

[36]  T. Hökfelt,et al.  Substance P: a pioneer amongst neuropeptides , 2001, Journal of internal medicine.

[37]  M. Raggenbass,et al.  Oxytocin receptor agonists enhance inhibitory synaptic transmission in the rat hippocampus by activating interneurons in stratum pyramidale , 2000, The European journal of neuroscience.

[38]  H. Eichenbaum.  A cortical–hippocampal system for declarative memory , 2000, Nature Reviews Neuroscience.

[39]  R. Schwarting,et al.  Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery , 2000, Neuropeptides.

[40]  S. File,et al.  The Role of the Dorsal Hippocampal Serotonergic and Cholinergic Systems in the Modulation of Anxiety , 2000, Pharmacology Biochemistry and Behavior.

[41]  J. Huston,et al.  Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P , 2000, Neuroscience Letters.

[42]  S. File,et al.  Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptors , 2000, Neuropharmacology.

[43]  M. Brandão,et al.  Anxiogenic effects of substance P and its 7–11 C terminal, but not the 1–7 N terminal, injected into the dorsal periaqueductal gray☆ , 1999, Peptides.

[44]  A. Meneses,et al.  5-HT system and cognition , 1999, Neuroscience & Biobehavioral Reviews.

[45]  J. Huston,et al.  The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection. , 1999, Neuroreport.

[46]  R. Vertes,et al.  Projections of the median raphe nucleus in the rat , 1999, The Journal of comparative neurology.

[47]  F. Fadda,et al.  Serotonin and acetylcholine release response in the rat hippocampus during a spatial memory task , 1999, Neuroscience.

[48]  A. Nistri,et al.  Modulation by substance P of synaptic transmission in the mouse hippocampal slice , 1998, The European journal of neuroscience.

[49]  J. Huston,et al.  Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region. , 1998, European journal of pharmacology.

[50]  C. Maggi,et al.  The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles , 1998, Neuropeptides.

[51]  Z. Borhegyi,et al.  Substance P innervation of the rat hippocampal formation , 1997, The Journal of comparative neurology.

[52]  Z. Borhegyi,et al.  Distinct substance P- and calretinin-containing projections from the supramammillary area to the hippocampus in rats; a species difference between rats and monkeys , 1997, Experimental Brain Research.

[53]  N. McNaughton.  Cognitive Dysfunction Resulting from Hippocampal Hyperactivity—A Possible Cause of Anxiety Disorder? , 1997, Pharmacology Biochemistry and Behavior.

[54]  L. Acsády,et al.  Immunostaining for substance P receptor labels GABAergic cells with distinct termination patterns in the hippocampus , 1997, The Journal of comparative neurology.

[55]  M. Brandão,et al.  Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test , 1996, Physiology & Behavior.

[56]  J. Calixto,et al.  Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. , 1996, European journal of pharmacology.

[57]  L. Swanson,et al.  Structural Evidence for Functional Domains in the Rat Hippocampus , 1996, Science.

[58]  S. File,et al.  Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus , 1996, Pharmacology Biochemistry and Behavior.

[59]  S. Netto,et al.  Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single restraint experience , 1996, Behavioural Brain Research.

[60]  R. Schwarting,et al.  Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region , 1995, Neuroscience.

[61]  J. Huston,et al.  The role of neuropeptides in learning: focus on the neurokinin substance P , 1995, Behavioural Brain Research.

[62]  S. File,et al.  5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. , 1994, European journal of pharmacology.

[63]  A. Bidziński,et al.  Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A a receptor agonists , 1993, Neuropharmacology.

[64]  M. Tohyama,et al.  Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. , 1993, Brain research. Molecular brain research.

[65]  G. M. Peterson,et al.  Morphological evidence for a substance P projection from medial septum to hippocampus , 1992, Peptides.

[66]  R. Vertes.  A PHA‐L analysis of ascending projections of the dorsal raphe nucleus in the rat , 1991, The Journal of comparative neurology.

[67]  C B Cave,et al.  The hippocampus, memory, and space , 1991, Hippocampus.

[68]  W. Kostowski,et al.  Intra-hippocampal buspirone in animal models of anxiety. , 1989, European journal of pharmacology.

[69]  M. Raggenbass,et al.  Tachykinins and bombesin excite non‐pyramidal neurones in rat hippocampus. , 1986, The Journal of physiology.

[70]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[71]  N. McNaughton,et al.  Comparison between the behavioural effects of septal and hippocampal lesions: A review , 1983, Neuroscience & Biobehavioral Reviews.

[72]  V. Erspamer.  The tachykinin peptide family , 1981, Trends in Neurosciences.

[73]  K. Lieb,et al.  Substance P Receptor Antagonists in Psychiatry , 2005, CNS drugs.

[74]  P. Mantyh.  Neurobiology of substance P and the NK1 receptor. , 2002, The Journal of clinical psychiatry.

[75]  F. H. Lopes da Silva,et al.  Cortico‐hippocampal communication by way of parallel parahippocampal‐subicular pathways , 2000, Hippocampus.

[76]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .